FDA approves United States' first-ever RSV vaccine
Published
The Food and Drug Administration on Wednesday approved GlaxoSmithKline's vaccine against the respiratory syncytial virus, making it the first authorized RSV shot in the U.S. Why it matters: GSK's vaccine is approved for adults aged 60 and older, a population that is particularly vulnerable to RSV.…
#rsv #gsk #fda #pfizer #petermarks #cdc